|
Host-Tumor Cell Interactions in Myeloma:
|
5P01CA078378-10
|
$2,008,736
|
$662,883
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Role of Cytokines in Myeloma Pathogenesis
|
5R01CA050947-16
|
$283,743
|
$42,561
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
THE THERAPY OF AML
|
2P01CA055164-15A1
|
$2,404,845
|
$601,211
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adult Leukemia Research Center
|
2P01CA018029-32
|
$5,086,500
|
$5,086,500
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pathogenesis of Notch Leukemia
|
5R01CA082308-09
|
$433,640
|
$108,410
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-02
|
$420,764
|
$420,764
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-13
|
$3,499,541
|
$1,749,771
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$23,155
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$12,636
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$756,461
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$6,935
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Immunobiology of Hybrid Resistance
|
5R01CA036922-24
|
$312,844
|
$312,844
|
Bennett, Michael
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$4,136
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$6,970
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$345,795
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
For Better and For Worse: Late Effects of Cancer and BMT on Spouse-Caregivers
|
5R03CA126401-02
|
$71,126
|
$71,126
|
Bishop, Michelle
|
UNIVERSITY OF FLORIDA
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
2R01CA072669-11
|
$298,185
|
$298,185
|
Blazar, Bruce
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Growth Regulation and Therapy of Leukemias and Lymphomas
|
5P01CA092372-05
|
$1,185,331
|
$296,333
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
1R01CA124996-01A1
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$589
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
1R01CA118880-01A1
|
$259,431
|
$259,431
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-04
|
$464,495
|
$232,248
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA016087-27
|
$2,563,433
|
$51,269
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Specialized Cancer Center Support Grant
|
2P30CA023100-23
|
$3,966,000
|
$118,980
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S1
|
$115,875
|
$3,476
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S2
|
$92,700
|
$2,781
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
THERAPY OF CML
|
5P01CA049639-19
|
$3,552,240
|
$1,953,732
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-15
|
$1,686,422
|
$1,129,903
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Therapeutic Manipulation of the B7-like Molecules
|
5R01CA098731-06
|
$310,442
|
$77,611
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Stem Cell Donor Enrollment and Retention in Korean Americans
|
1R03CA130726-01
|
$63,000
|
$63,000
|
CHOE, JOHN
|
UNIVERSITY OF WASHINGTON
|
|
Hematopoietic Stem Cells for Transplantation
|
3P01CA070970-09S1
|
$775,678
|
$775,678
|
CIVIN, CURT
|
JOHNS HOPKINS UNIVERSITY
|
|
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
|
5R01CA089511-07
|
$293,771
|
$73,443
|
COHEN, PETER
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
|
1R01CA120956-01A1
|
$292,600
|
$146,300
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
1R01CA124782-01A1
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Imaging Infused CD19 Specific T Cells in the Tumor
|
1R21CA129390-01
|
$169,680
|
$169,680
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
In vivo targeted DC vaccine to activate anti-tumor CTL
|
5R01CA112065-03
|
$108,340
|
$108,340
|
CUI, YAN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Moffitt Cancer Center Support Grant
|
2P30CA076292-09
|
$2,780,246
|
$55,605
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S1
|
$124,501
|
$2,490
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S2
|
$192,356
|
$3,847
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-09S3
|
$178,221
|
$3,564
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Selective Therapy of Neuroblastoma
|
5R01CA079763-09
|
$213,341
|
$213,341
|
DANKS, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Poor competition in hematopoietic stem/progenitor pools favors tumorigenesis
|
5R01CA109657-03
|
$214,532
|
$21,453
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Molecular & Genetic Determinants of Outcome in Breast Ca
|
5R01CA104581-04
|
$296,417
|
$148,209
|
DEMICHELE, ANGELA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
3R01CA077544-09S1
|
$107,242
|
$107,242
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
5R01CA077544-09
|
$466,660
|
$466,660
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S1
|
$110,040
|
$1,100
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S2
|
$98,300
|
$983
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-33
|
$5,104,634
|
$51,046
|
Diasio, Robert
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
Total relevant funding to Organ Transplantation Research for this search: $71,467,297
|